Category: medtronic

Recent advances in Life Sciences | May 2018 Newsletter | MaxVal

The article presents a base editing approach to expand the scope and efficiency of CRISPR mediated genome editing.

Continue reading

Recent advances in Diabetes Management | April 2018 Newsletter | MaxVal

The article addresses Medtronic’s recent FDA approval of the Guardian™ Connect Continuous Glucose Monitoring (CGM) system. A brief overview of all the clinical studies related to CGM has been presented.

Continue reading